ArticleJournal of primary care & community health
IMPACT-DM: Improving Management of Poorly Controlled Type 2 Diabetes (A1c ≥9%) Through Coordinated, Team-Based Care in Federally Qualified Health Centers.
Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uncontrolled type 2 diabetes disproportionately affects underserved populations and contributes to substantial morbidity, mortality, and healthcare costs. In Federally Qualified Health Centers (FQHCs), infrequent follow-up and inconsistent use of real-time glycemic data limit timely treatment intensification. In a multi-site FQHC serving underserved communities, baseline data demonstrated persistently high rates of uncontrolled diabetes (A1c ≥9%) despite access to in-house point-of-care A1c testing. Provider-dependent workflows, inconsistent follow-up, and low patient engagement were identified as key barriers to sustained glycemic control.ObjectiveTo evaluate the impact of a monthly, interprofessional follow-up model incorporating medical assistant (MA)-led point-of-care A1c testing and clinical pharmacy integration on glycemic control and cardiometabolic outcomes in an FQHC setting.MethodsA 12-month quality improvement initiative using the Plan-Do-Study-Act framework was implemented across multiple FQHC sites. Adults with type 2 diabetes and A1c ≥9% were enrolled. The primary outcome was the inverse diabetes quality measure (A1c ≥9%). Secondary outcomes included A1c distribution, provider-level A1c improvement, blood pressure control (<130/80 mmHg), and LDL cholesterol control (<100 mg/dL).ResultsAn initial four-month pilot cohort of 138 patients with A1c ≥9%, managed by two primary care providers, demonstrated rapid glycemic improvement, with 81.8% achieving A1c <9%. These findings informed workflow refinement and organization-wide implementation over the subsequent year, during which the inverse diabetes quality measure improved from 24.1% to 18.6% (absolute reduction of 5.5 percentage points). Concurrent improvements were observed in blood pressure control (36.0% to 40.6%) and LDL cholesterol control (45.0% to 47.0%).ConclusionsA monthly interprofessional follow-up model with MA-led in-house A1c testing and clinical pharmacy integration was associated with improved glycemic and cardiometabolic outcomes in an FQHC setting. This scalable approach supports value-based chronic disease management in underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.